Quince Therapeutics Inc. (QNCX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Quince Therapeutics Inc.

    NASDAQ: QNCX · Real-Time Price · USD
    1.65
    0.01 (0.61%)
    At close: Oct 03, 2025, 3:59 PM
    1.69
    2.42%
    Pre-market: Oct 06, 2025, 08:17 AM EDT

    Quince Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.42 -1.25 -0.41 -4.17
    PEG Ratio
    		 -0.03 0.03 0.01 -0.27
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.68 0.46 0.21 3.16
    P/FCF Ratio
    		 -2.52 -2.12 -0.48 -5.94
    P/OCF Ratio
    		 -2.54 -2.14 -0.48 -5.96
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.49 0.16 0.00 0.01
    Quick Ratio
    		 6.05 8.09 30.55 7.85
    Current Ratio
    		 6.05 8.09 30.55 7.85
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a n/a -91.58 n/a
    Return on Equity
    		 -1.89 -0.37 -0.51 -0.76
    Return on Assets
    		 -0.5 -0.19 -0.5 -0.68
    Return on Invested Capital
    		 -0.53 -0.22 -0.51 -0.75
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist